Intarcia is a biotech company dedicated to redesigning the treatment, prevention and experience of chronic disease.
| Date | Funding Round | Funding Raised | Price per Share | IPO Valuation |
|---|---|---|---|---|
| 9/15/2016 | Series EE | $3.94B | $XXX.XX | $XXX.XX |
| 7/4/2014 | Series DD | $1.63B | $XXX.XX | $XXX.XX |
| 11/15/2012 | Series CC | $612MM | $XXX.XX | $XXX.XX |
| 1/14/2010 | Series BB-3 | $138MM | $XXX.XX | $XXX.XX |
| 4/28/2008 | Series BB-2 | $112MM | $XXX.XX | $XXX.XX |
| 3/9/2007 | Series BB-1 | $103.02MM | $XXX.XX | $XXX.XX |
| 12/1/2004 | Series AA | $98MM | $XXX.XX | $XXX.XX |
